个人科研网厅 | | 帮助
首都医科大学宣武医院知识库
高级检索
当前位置： 首页 > 详情页

Human midbrain dopaminergic progenitors

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Wang Yu-Kai[1,2,3,4] * ; Feng Lin[1,4,5] ; Ma Ai-Jin[6,7] ; Hao Jie[1,2,3,4,6] ; Zhang Ying[6,8] ; Chen Yue-Jun[9,10] ; Chen Zhi-Guo[11,12] ; Yu Jun-Ying[6,8] ; Liu Yan[13] ; Liu Chang-Mei[1,2,3,5] ; Zhang Yu[6,14] ; Wang Chang-Lin[6,15] ; Teng Zhao-Qian[1,2,3,5] ; Zhou Jia-Xi[6,16] ; Li Tian-Qing[6,17,18] ; Wang Liu[1,2,3,5] ; Fu Bo-Qiang[6,19] ; Fu Yu Vincent[5,20] ; Zhu Li-Jun[6,21] ; Liang Ling-Min[1,4,5,6] ; Cao Jia-Ni[1,2,3,6] ; Wang Lei[1,2,3,4,6] ; Zhou Qi[1,2,3,5,6] ; Xiang Andy Peng[6,22] ; Hu Bao-Yang[1,2,3,5] ; Zhao Tong-Biao[1,2,3,5,6] ;
机构： [1]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. [2]Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China. [3]Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China. [4]National Stem Cell Resource Center, Chinese Academy of Sciences, Beijing, China. [5]University of Chinese Academy of Sciences, Beijing, China. [6]Chinese Society for Stem Cell Research, Shanghai, China. [7]Beijing Technology and Business University, Beijing, China. [8]Nuwacell Biotechnologies Co., Ltd., Hefei, China. [9]Institute of Neuroscience, Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China. [10]Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China. [11]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, China. [12]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China. [13]Institute for Stem Cell and Neural Regeneration, State Key Laboratory of Reproductive Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China. [14]Zephyrm Biotechnologies Co., Ltd., Beijing, China. [15]China National Institute of Standardization, Beijing, China. [16]Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. [17]State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China. [18]Yunnan Key Laboratory of Primate Biomedical Research, Kunming, Yunnan, China. [19]National Institute of Metrology, Beijing, China. [20]State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. [21]Institute of Scientific and Technical Information of China, Beijing, China. [22]Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou, China.
出处：
DOI： 10.1111/cpr.13563
ISSN：

摘要：
Human midbrain dopaminergic progenitors (mDAPs) are one of the most representative cell types in both basic research and clinical applications. However, there are still many challenges for the preparation and quality control of mDAPs, such as the lack of standards. Therefore, the establishment of critical quality attributes and technical specifications for mDAPs is largely needed. "Human midbrain dopaminergic progenitor" jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research, is the first guideline for human mDAPs in China. This standard specifies the technical requirements, test methods, inspection rules, instructions for usage, labelling requirements, packaging requirements, storage requirements, transportation requirements and waste disposal requirements for human mDAPs, which is applicable to the quality control for human mDAPs. It was originally released by the China Society for Cell Biology on 30 August 2022. We hope that the publication of this guideline will facilitate the institutional establishment, acceptance and execution of proper protocols, and accelerate the international standardization of human mDAPs for clinical development and therapeutic applications.© 2023 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.

基金：
CAS Project for Young Scientists in Basic Research, Grant/Award Number: YSBR-041; Joint Funds of the National Natural Science Foundation of China, Grant/Award Number: U21A20396; National Key Research and Development Program of China, Grant/Award Numbers: 2018YFA0108400, 2018YFE0204400, 2019YFA0110800, 2019YFA0903800, 2021YFA1101600; National Natural Science Foundation of China, Grant/Award Number: 31970821
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
最新[2023]版：
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
JCR分区：
出版当年[2022]版：
Q1 CELL BIOLOGY
最新[2023]版：
Q2 CELL BIOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. [2]Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China. [3]Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China. [4]National Stem Cell Resource Center, Chinese Academy of Sciences, Beijing, China.
通讯作者：
通讯机构： [1]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. [2]Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China. [3]Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China. [5]University of Chinese Academy of Sciences, Beijing, China. [6]Chinese Society for Stem Cell Research, Shanghai, China. [22]Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou, China.
推荐引用方式(GB/T 7714)：
Wang Yu-Kai,Feng Lin,Ma Ai-Jin,et al.Human midbrain dopaminergic progenitors[J].CELL PROLIFERATION.2024,57(4):doi:10.1111/cpr.13563.
APA：
Wang Yu-Kai,Feng Lin,Ma Ai-Jin,Hao Jie,Zhang Ying...&Zhao Tong-Biao.(2024).Human midbrain dopaminergic progenitors.CELL PROLIFERATION,57,(4)
MLA：
Wang Yu-Kai,et al."Human midbrain dopaminergic progenitors".CELL PROLIFERATION 57..4(2024)

资源点击量：16409 今日访问量：0 总访问量：869 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持：重庆聚合科技有限公司 地址：北京市西城区长椿街45号宣武医院